AMG National Trust Bank’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,684
Closed -$1.17M 447
2024
Q2
$1.17M Buy
5,684
+32
+0.6% +$7.25K 0.03% 275
2024
Q1
$1.53M Sell
5,652
-2
-0% -$478 0.04% 222
2023
Q4
$1.34M Sell
5,654
-55
-1% -$10.8K 0.04% 240
2023
Q3
$1.12M Buy
+5,709
New +$1.17M 0.04% 260

Other funds holding CRL

AMG National Trust Bank's CRL Position: Q3 2024 in Review

AMG National Trust Bank sold out of Charles River Laboratories (CRL) in Q3 2024, closing a stake of 5,684 shares — an estimated $1.17M sold.

AMG National Trust Bank first reported a position in CRL in Q3 2023 and held it in 4 quarters. The position peaked at $1.53M in Q1 2024. 627 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

  • AMG National Trust Bank reported no remaining Charles River Laboratories position as of Q3 2024 after selling out during the quarter.
  • AMG National Trust Bank sold 5,684 Charles River Laboratories shares in Q3 2024, an estimated $1.17M.
  • AMG National Trust Bank first reported a position in Charles River Laboratories in Q3 2023 and held it in 4 quarters.
  • AMG National Trust Bank's Charles River Laboratories position peaked at $1.53M in Q1 2024.
  • 627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on AMG National Trust Bank's 13F filing for Q3 2024, filed 7 Nov 2024.